The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of epidermal growth factor (EGF) vaccine CIMAvax in combination with pembrolizumab in first line and maintenance setting in advanced non–small cell lung cancer patients.
 
Prantesh Jain
Employment - Athenex (I)
Research Funding - AADi (Inst); Harpoon therapeutics (Inst); Iovance Biotherapeutics (Inst); Sanofi (Inst); SOPHiA Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Combination of quantitative features from H&E biopsies and CT scans predicts response to chemotherapy and overall survival in Small Cell Lung Cancer (SCLC) US Patent Application No. 63/212,263; Computer extracted features from baseline CT scans predicts response to platinum-based chemotheraphy and is prognostic of overall survival in small cell lung cancer (SCLC) US Patent Application No. 63/212,247
 
Alan Hutson
No Relationships to Disclose
 
Cayla Janes
No Relationships to Disclose
 
Debora S. Bruno
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca (I); Bristol Meyers Squibb; Daiichi Sankyo/Astra Zeneca; Lilly; Mirati Therapeutics; Novartis; Syneos Health
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Dragonfly Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Seagen (Inst)
 
Greg Andrew Durm
Honoraria - AstraZeneca; Curio Science; Dava Oncology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Ashish Sangal
No Relationships to Disclose
 
Bhoomi Mehrotra
Other Relationship - UptoDate
 
Tania Crombet Ramos
No Relationships to Disclose
 
Kalet Leon
No Relationships to Disclose
 
Grace K. Dy
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Mirati Therapeutics
Research Funding - AMGEN (Inst); AstraZeneca (Inst); Bioatla (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Mirati Therapeutics (Inst); regeneron (Inst); Revolution Medicines (Inst); Sanofi (Inst)